Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-20-078441

Director bought 650 shares at $78.50 ($51,025)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2020-06-29 Purchase +650 $78.50 $51,025 403,698 D
Open-market purchases · 650 sh · avg $78.50 · $51,025
Loading xslF345X03/a4.xml…